MorphoSys Statistics
Share Statistics
MorphoSys has 150.65M
shares outstanding. The number of shares has increased by 0%
in one year.
| Shares Outstanding | 150.65M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 29.77% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 2,680 |
| FTD / Avg. Volume | 5.69% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -6.48 and the forward
PE ratio is null.
MorphoSys's PEG ratio is
-0.27.
| PE Ratio | -6.48 |
| Forward PE | n/a |
| PS Ratio | 5.16 |
| Forward PS | n/a |
| PB Ratio | 25.06 |
| P/FCF Ratio | -4.12 |
| PEG Ratio | -0.27 |
Financial Ratio HistoryEnterprise Valuation
MorphoSys has an Enterprise Value (EV) of 1.71B.
| EV / Sales | 7.16 |
| EV / EBITDA | -17.46 |
| EV / EBIT | -5.77 |
| EV / FCF | -5.71 |
Financial Position
The company has a current ratio of 3.08,
with a Debt / Equity ratio of 12.97.
| Current Ratio | 3.08 |
| Quick Ratio | 2.84 |
| Debt / Equity | 12.97 |
| Debt / EBITDA | -6.51 |
| Debt / FCF | -2.13 |
| Interest Coverage | -2.3 |
Financial Efficiency
Return on Equity is -386.82% and Return on Invested Capital is -36.63%.
| Return on Equity | -386.82% |
| Return on Assets | -9.36% |
| Return on Invested Capital | -36.63% |
| Revenue Per Employee | $513,530.85 |
| Profits Per Employee | $-408,909.91 |
| Employee Count | 464 |
| Asset Turnover | 0.12 |
| Inventory Turnover | 0.94 |
Taxes
| Income Tax | -1.19M |
| Effective Tax Rate | 0.62% |
Stock Price Statistics
The stock price has increased by 5.04% in the
last 52 weeks. The beta is 0.66, so MorphoSys's
price volatility has been higher than the market average.
| Beta | 0.66 |
| 52-Week Price Change | 5.04% |
| 50-Day Moving Average | 18.46 |
| 200-Day Moving Average | 14.74 |
| Relative Strength Index (RSI) | 60.22 |
| Average Volume (20 Days) | 47,073 |
Income Statement
In the last 12 months, MorphoSys had revenue of 238.28M
and earned -189.73M
in profits. Earnings per share was -1.38.
| Revenue | 238.28M |
| Gross Profit | 179.92M |
| Operating Income | -252.48M |
| Net Income | -189.73M |
| EBITDA | -97.74M |
| EBIT | -92.27M |
| Earnings Per Share (EPS) | -1.38 |
Full Income StatementBalance Sheet
The company has 158.5M in cash and 635.93M in
debt, giving a net cash position of -477.43M.
| Cash & Cash Equivalents | 158.5M |
| Total Debt | 635.93M |
| Net Cash | -477.43M |
| Retained Earnings | -1.01B |
| Total Assets | 1.83B |
| Working Capital | 187.17M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -295.84M
and capital expenditures -2.87M, giving a free cash flow of -298.71M.
| Operating Cash Flow | -295.84M |
| Capital Expenditures | -2.87M |
| Free Cash Flow | -298.71M |
| FCF Per Share | -2.18 |
Full Cash Flow StatementMargins
Gross margin is 75.51%, with operating and profit margins of -105.96% and -79.63%.
| Gross Margin | 75.51% |
| Operating Margin | -105.96% |
| Pretax Margin | -80.13% |
| Profit Margin | -79.63% |
| EBITDA Margin | -41.02% |
| EBIT Margin | -105.96% |
| FCF Margin | -125.36% |
